ATE397099T1 - Oligonukleotidprimer zur reversen transkription für den effizienten nachweis von hiv-1 und hiv-2 und methoden ihrer verwendung - Google Patents

Oligonukleotidprimer zur reversen transkription für den effizienten nachweis von hiv-1 und hiv-2 und methoden ihrer verwendung

Info

Publication number
ATE397099T1
ATE397099T1 AT00300792T AT00300792T ATE397099T1 AT E397099 T1 ATE397099 T1 AT E397099T1 AT 00300792 T AT00300792 T AT 00300792T AT 00300792 T AT00300792 T AT 00300792T AT E397099 T1 ATE397099 T1 AT E397099T1
Authority
AT
Austria
Prior art keywords
hiv
methods
reverse transcription
oligonucleotide primer
efficient detection
Prior art date
Application number
AT00300792T
Other languages
English (en)
Inventor
David R Patterson
John A Puskas
Keming Song
Jeffrey M Linnen
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Application granted granted Critical
Publication of ATE397099T1 publication Critical patent/ATE397099T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT00300792T 1999-02-02 2000-02-01 Oligonukleotidprimer zur reversen transkription für den effizienten nachweis von hiv-1 und hiv-2 und methoden ihrer verwendung ATE397099T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11841799P 1999-02-02 1999-02-02

Publications (1)

Publication Number Publication Date
ATE397099T1 true ATE397099T1 (de) 2008-06-15

Family

ID=22378462

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00300792T ATE397099T1 (de) 1999-02-02 2000-02-01 Oligonukleotidprimer zur reversen transkription für den effizienten nachweis von hiv-1 und hiv-2 und methoden ihrer verwendung

Country Status (13)

Country Link
US (1) US6303293B1 (de)
EP (1) EP1026263B1 (de)
JP (1) JP2000342274A (de)
KR (1) KR100901084B1 (de)
CN (1) CN1186455C (de)
AT (1) ATE397099T1 (de)
AU (1) AU761066B2 (de)
CA (1) CA2295920C (de)
DE (1) DE60038993D1 (de)
DK (1) DK1026263T3 (de)
ES (1) ES2306648T3 (de)
NO (1) NO327727B1 (de)
PT (1) PT1026263E (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8036741B2 (en) 1996-04-30 2011-10-11 Medtronic, Inc. Method and system for nerve stimulation and cardiac sensing prior to and during a medical procedure
US6449507B1 (en) 1996-04-30 2002-09-10 Medtronic, Inc. Method and system for nerve stimulation prior to and during a medical procedure
US7269457B2 (en) 1996-04-30 2007-09-11 Medtronic, Inc. Method and system for vagal nerve stimulation with multi-site cardiac pacing
US7225019B2 (en) 1996-04-30 2007-05-29 Medtronic, Inc. Method and system for nerve stimulation and cardiac sensing prior to and during a medical procedure
US6479523B1 (en) * 1997-08-26 2002-11-12 Emory University Pharmacologic drug combination in vagal-induced asystole
CA2376903A1 (en) 1999-06-25 2001-01-04 Emory University Devices and methods for vagus nerve stimulation
JP4824236B2 (ja) * 1999-07-09 2011-11-30 ジェン−プローブ・インコーポレーテッド 核酸増幅によるｈｉｖ−１の検出
CA2318730C (en) * 1999-09-20 2008-01-22 Ortho-Clinical Diagnostics, Inc. A method for reverse transcribing rna isolated in dry form
US6487446B1 (en) 2000-09-26 2002-11-26 Medtronic, Inc. Method and system for spinal cord stimulation prior to and during a medical procedure
EP1399585B1 (de) 2000-10-23 2008-02-20 Gen-Probe Incorporated Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
EP2251442B9 (de) * 2003-12-19 2012-04-25 Gen-Probe Incorporated Zusammensetzungen, Verfahren und Kits zum Nachweis der Nukleinsäuren von HIV-1 und HIV-2
CN100340673C (zh) * 2005-02-03 2007-10-03 上海科华生物工程股份有限公司 人类免疫缺陷病毒hiv－1核酸扩增－荧光定量检测试剂盒
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
US8620425B2 (en) 2010-04-29 2013-12-31 Medtronic, Inc. Nerve signal differentiation in cardiac therapy
US8639327B2 (en) 2010-04-29 2014-01-28 Medtronic, Inc. Nerve signal differentiation in cardiac therapy
US8406868B2 (en) 2010-04-29 2013-03-26 Medtronic, Inc. Therapy using perturbation and effect of physiological systems
US8706223B2 (en) 2011-01-19 2014-04-22 Medtronic, Inc. Preventative vagal stimulation
US8781582B2 (en) 2011-01-19 2014-07-15 Medtronic, Inc. Vagal stimulation
US8718763B2 (en) 2011-01-19 2014-05-06 Medtronic, Inc. Vagal stimulation
US8725259B2 (en) 2011-01-19 2014-05-13 Medtronic, Inc. Vagal stimulation
US8781583B2 (en) 2011-01-19 2014-07-15 Medtronic, Inc. Vagal stimulation
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
WO2013111800A1 (ja) 2012-01-25 2013-08-01 独立行政法人科学技術振興機構 Ｈｉｖ検出用オリゴヌクレオチド、ｈｉｖ検出キット、及びｈｉｖ検出方法
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (de) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10385410B2 (en) 2014-05-27 2019-08-20 Universite Paris Descartes In vitro method for the detection and quantification of HIV-2
EP3069730A3 (de) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
MA45783A (fr) * 2016-07-29 2019-06-05 Juno Therapeutics Inc Procédés d'évaluation de la présence ou de l'absence d'un virus compétent pour la réplication
WO2018045425A1 (en) * 2016-09-07 2018-03-15 St Vincent's Hospital Sydney Limited Methods of detecting lentivirus
CN106498095A (zh) * 2016-11-14 2017-03-15 湖南圣湘生物科技有限公司 一种人类免疫性缺陷病毒2型核酸检测试剂盒

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE423856T1 (de) 1989-06-02 2009-03-15 Pasteur Institut Nukleotid-sequenzen von hiv-1, hiv-2 und siv retrovirusgenomen, ihre verwendung zur amplifizierung von pol-sequenzen dieser retroviren und zur in vitro diagnostik von diesen viren verursachten infektionen
US5478724A (en) 1991-08-16 1995-12-26 The Rockefeller University Lentivirus-specific nucleotide probes and methods of use
ATE174382T1 (de) 1992-10-06 1998-12-15 Dade Behring Marburg Gmbh Retrovirus aus der hiv-gruppe und dessen verwendung
US5599662A (en) * 1995-02-17 1997-02-04 Hoffmann-La Roche Inc. Oliconucleotide primers and probes for the detection of HIV-1
US5962665A (en) 1997-06-16 1999-10-05 Abbott Laboratories Nucleic acid primers and probes for detecting HIV-1 and HIV-2
US6001558A (en) * 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2

Also Published As

Publication number Publication date
PT1026263E (pt) 2008-08-27
DK1026263T3 (da) 2008-09-08
ES2306648T3 (es) 2008-11-16
KR100901084B1 (ko) 2009-06-08
KR20010014470A (ko) 2001-02-26
AU761066B2 (en) 2003-05-29
EP1026263A2 (de) 2000-08-09
US6303293B1 (en) 2001-10-16
NO327727B1 (no) 2009-09-14
AU1482900A (en) 2000-08-03
CN1271020A (zh) 2000-10-25
DE60038993D1 (de) 2008-07-10
EP1026263B1 (de) 2008-05-28
CN1186455C (zh) 2005-01-26
EP1026263A3 (de) 2000-10-11
NO20000513L (no) 2000-08-03
CA2295920A1 (en) 2000-08-02
JP2000342274A (ja) 2000-12-12
CA2295920C (en) 2013-10-29
NO20000513D0 (no) 2000-02-01

Similar Documents

Publication Publication Date Title
ATE397099T1 (de) Oligonukleotidprimer zur reversen transkription für den effizienten nachweis von hiv-1 und hiv-2 und methoden ihrer verwendung
DE60041940D1 (de) Oligonukleotidprimer zur effizienten Detektion von Hepatitis C Virus (HCV) sowie Verwendungsverfahren
ATE315667T1 (de) Amplifizierung und detektion von hiv-1 und/oder hiv-2
DE60310297D1 (de) Methode für die direkte Gewinnung und Amplifikation von integrierten Viren aus zellulärer Gewebe-DNA
DE69838911D1 (de) In-vitro Verfahren zur Bereitstellung von Fragmenten für die DNS Sequenzierung
ATE495240T1 (de) Ligand des zelleintritt-vermittelnden proteins von herpes simplex virus und methoden zu dessen verwendung
DE60132924D1 (de) Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
RU98100921A (ru) Праймеры для обнаружения вич-1
DE69836395D1 (de) Primern zum Nachweis von HIV-1
DE60009977D1 (de) Oligonukleotidstartermoleküle zur effizienten Multiplexdetektion vom Hepatitis C Virus (HCV) und vom Humanen Immundefizienzvirus (HIV) und Methoden zu ihrer Verwendung
ATE349533T1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
EP1407042A4 (de) Mittel und verfahren zur überwachung einer antiretroviralen proteaseinhibitortherapie und als richtschnur für therapeutische entscheidungen bei der behandlung von hiv/aids
DE60316316D1 (de) Verbesserung bei fässern zur behandlung von fellen, häuten und leder
DE502004003467D1 (de) Von vca-p18 kapsidantigen des epstein-barr-virus abgeleitete peptide und ihre verwendung
ATE267253T1 (de) Von htlv-i und htlv-ii gp21 abgeleitete peptide zur diagnostischen verwendung
EP1370697A4 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion und verfahren zu deren verwendung
ATE447622T1 (de) Methoden und zusammensetzungen zur diagnose und behandlung von pseudoxanthoma elasticum und ähnlichen zuständen
WO1999007885A3 (de) Verwendung von primern für universelle fingerprint-analysen
TR200000435T2 (tr) Bulaşıcı akdeniz humması geni.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1026263

Country of ref document: EP